InterCure Ltd. INCR

INCR Company Overview

InterCure Ltd. (INCR) is an Israel-based life sciences company operating primarily in the medical cannabis industry. The company focuses on the cultivation, production, distribution, and commercialization of pharmaceutical-grade medical cannabis products, serving regulated medical markets. InterCure operates across the cannabis value chain, emphasizing compliance with stringent medical and regulatory standards and positioning itself as a premium provider in physician-prescribed cannabis therapies.

The company’s core revenue drivers are medical cannabis cultivation, branded product sales, and distribution through controlled channels. InterCure primarily serves licensed medical cannabis patients, healthcare providers, and pharmacies, with a strategic emphasis on brand-driven differentiation, quality control, and clinical credibility. Founded in 1994 as a biotechnology company, InterCure underwent a strategic transformation beginning in 2018, pivoting decisively toward the medical cannabis sector following regulatory reforms in Israel that enabled commercial-scale medical cannabis production and exports.